Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
REHOVOT, Israel, Aug. 30, 2024 ( GLOBE NEWSWIRE ) -- Purple Biotech Ltd. ( "Purple Biotech" or "the Company" ) ( NASDAQ/TASE: PPBT ) , a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced its executive management ...
| Ticker |
Sentiment |
Impact |
|
BMY
|
Neutral
|
4 %
|
|
PPBT
|
Neutral
|
14 %
|
